Literature DB >> 15862411

The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease.

Gang Hu1, Pekka Jousilahti, Qing Qiao, Markku Peltonen, Shuichi Katoh, Jaakko Tuomilehto.   

Abstract

OBJECTIVES: The goal of this study is to compare the magnitude of diabetes and myocardial infarction (MI) at baseline and during follow-up on cause-specific and all-cause mortality.
BACKGROUND: History of both MI and diabetes are strong predictors of coronary heart disease (CHD) death. However, gender-specific data on the joint effect of diabetes and MI, and particularly on the effect of incident diabetes and MI developed during the follow-up, on CHD mortality are scarce.
METHODS: The baseline cohort study included 2,416 patients with prior diabetes or MI at baseline; the follow-up cohort study included 4,315 patients with incident diabetes or MI diagnosed during the follow-up.
RESULTS: In the baseline cohort study, men with prior MI had a 20% to 80% increased risk of CHD or total mortality, but women with prior MI had a 43% to 45% decreased risk of CHD or total mortality in comparison with men and women with prior diabetes. In the follow-up cohort study, men and women with incident MI had a higher risk of CHD mortality (hazard ratio [HR] 2.15 in men and 1.65 in women), and an almost similar risk of total mortality (HR 0.95 in men and 1.02 in women) in comparison with men and women with incident diabetes.
CONCLUSIONS: In men, MI at baseline or during follow-up confers a greater risk on CHD mortality than diabetes does. In women, prior MI at baseline confers a lower risk on CHD mortality than prior diabetes does, but incident MI during follow-up confers a greater risk than incident diabetes does. In both men and women, total mortality is similar for incident MI and diabetes.

Entities:  

Mesh:

Year:  2005        PMID: 15862411     DOI: 10.1016/j.jacc.2005.01.039

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

Review 1.  Adverse pregnancy outcomes and cardiovascular risk factor management.

Authors:  Puja K Mehta; Margo Minissian; C Noel Bairey Merz
Journal:  Semin Perinatol       Date:  2015-07-06       Impact factor: 3.300

2.  Postpartum dyslipidaemia in women diagnosed with gestational diabetes mellitus.

Authors:  A C O'Higgins; Vicky O'Dwyer; Clare O'Connor; Sean F Daly; Brendan T Kinsley; Michael J Turner
Journal:  Ir J Med Sci       Date:  2016-07-11       Impact factor: 1.568

3.  The effect of diabetes and stroke at baseline and during follow-up on stroke mortality.

Authors:  G Hu; P Jousilahti; C Sarti; R Antikainen; J Tuomilehto
Journal:  Diabetologia       Date:  2006-08-01       Impact factor: 10.122

Review 4.  Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome.

Authors:  Pantelis A Sarafidis; Samy I McFarlane; George L Bakris
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

Review 5.  Update on type 2 diabetes as a cardiovascular disease risk equivalent.

Authors:  Johanna Kuusisto; Markku Laakso
Journal:  Curr Cardiol Rep       Date:  2013-02       Impact factor: 2.931

6.  Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials.

Authors:  Samia Mora; Robert J Glynn; Judith Hsia; Jean G MacFadyen; Jacques Genest; Paul M Ridker
Journal:  Circulation       Date:  2010-02-22       Impact factor: 29.690

Review 7.  [Diabetes mellitus and coronary artery disease--a high risk combination].

Authors:  V Schächinger; M B Britten; A M Zeiher
Journal:  Clin Res Cardiol       Date:  2006-01       Impact factor: 5.460

Review 8.  A comprehensive view of sex-specific issues related to cardiovascular disease.

Authors:  Louise Pilote; Kaberi Dasgupta; Veena Guru; Karin H Humphries; Jennifer McGrath; Colleen Norris; Doreen Rabi; Johanne Tremblay; Arsham Alamian; Tracie Barnett; Jafna Cox; William Amin Ghali; Sherry Grace; Pavel Hamet; Teresa Ho; Susan Kirkland; Marie Lambert; Danielle Libersan; Jennifer O'Loughlin; Gilles Paradis; Milan Petrovich; Vicky Tagalakis
Journal:  CMAJ       Date:  2007-03-13       Impact factor: 8.262

Review 9.  Stem cells in the diabetic infarcted heart.

Authors:  Carley E Glass; Pawan K Singal; Dinender K Singla
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

10.  Age-dependent differences in diabetes and acute hyperglycemia between men and women with ST-elevation myocardial infarction: a cohort study.

Authors:  Amber M Otten; Jan Paul Ottervanger; Jorik R Timmer; Arnoud Wj van 't Hof; Jan-Henk E Dambrink; At Marcel Gosselink; Jan Ca Hoorntje; Harry Suryapranata; Angela Hem Maas
Journal:  Diabetol Metab Syndr       Date:  2013-07-04       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.